No. Sichuan Biokin Pharmaceutical (688506.SS) does not pass the AAOIFI Shari’ah Standard 21 screen.
Yes. Sichuan Biokin Pharmaceutical (688506.SS) passes the Catholic screen based on the USCCB investment guidelines.
Yes. Sichuan Biokin Pharmaceutical (688506.SS) passes the Biblically Responsible Investing (BRI) screen.